Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lactobacillus acidophilus LA-5 is a clinically studied probiotic strain that produces lactic acid and bacteriocins to inhibit pathogenic bacteria. It enhances immune function through modulation of gut-associated lymphoid tissue and reduces antibiotic-associated diarrhea by up to 60%.
Reported Benefits (Provisional)
Origin & History
Lactobacillus acidophilus LA-5 is a probiotic strain isolated from human intestinal microbiota. It is produced through fermentation and is used in dietary supplements and functional foods.
Research Narrative (Provisional)
Lactobacillus acidophilus LA-5 has been studied in multiple RCTs, showing efficacy in supporting digestive and immune health. Meta-analyses confirm its benefits in various health conditions.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains live probiotic cultures. - Produces lactic acid, supporting gut health. - Rich in bioactive compounds that modulate the immune system.
Reported Mechanism (Provisional)
LA-5 produces lactic acid and bacteriocins that create an acidic environment inhibiting pathogenic bacteria like E. coli and Clostridium difficile. The strain adheres to intestinal epithelial cells and stimulates secretory IgA production while modulating cytokine responses through Toll-like receptor pathways. It enhances tight junction proteins like claudin-1 and occludin to maintain intestinal barrier integrity.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving over 1,200 participants demonstrate LA-5's efficacy in reducing antibiotic-associated diarrhea incidence by 42-60%. A systematic review of 12 studies showed significant reduction in diarrhea duration and severity when administered at doses of 1-10 billion CFU daily. Clinical evidence supports immune enhancement with increased natural killer cell activity and reduced inflammatory markers like TNF-α. However, most studies are short-term (2-12 weeks) with limited long-term safety data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.